Table 3.
Red blood cell transfusion | |||
---|---|---|---|
Year | Society | Recommendations | Reference |
1988 | NIH Consensus Conference | < 7 g/dl (acute) | JAMA 1988;260:2700 [71] |
1992 | Am Coll Physicians (ACP) | No number | Ann Int Med 1992;116:393–402 [72] |
1996/2006 | AmerSocAnesth (ASA) | < 6 g/dl (acute) No number |
Anesth 1996;84:732–747 [73] Anesth 2006;105:198–208 [74] |
1997/1998 | Can Med Assoc (CMA) | No number | Can Med Assoc J 1997;156: S1–24 [60] J Emerg Med 1998;16:129–31 [75] |
1998 | Coll Amer Path (CAP) | 6 g/dl (acute) | Arch Path Lab Med 1998;122:130–8 [76] |
2001/2012 | Br Com Stand Haematol | No number 7–8 g/dla |
Br J Haematol 2001;113:24–31 [77] http://www.bcshguidelines.com/documents/BCSH_Blood_Admin_-_addendum_August_2012.pdf[78] |
2001 | Australasian Soc Blood Trans | 7 g/dl | http://www.nhmrc.health.gov.au[79] |
2007/2011 | Soc Thor Surg (STS) SocCardvascAnesth (CVA) |
7 g/dl or 8 g/dla |
Ann ThoracSurg 2007;83:S27–86 [80] Ann ThoracSurg 2011;91:944–82 [81] |
2009 | ACCM SCCM |
7 g/dl 7 g/dl |
Crit Care Med 2009;37:3124–57 [82] J Trauma 2009;67:1439–42 [83] |
2011 | SABM | 8 g/dl | Trans Med Rev 2011;232–246 [84] |
2012 | National Blood Authority, Australia | No number | http://www.nba.gov.au/guidelines/review.html[86] |
2012 | AABB | 7–8 g/dl or 8 g/dlb | Ann Int Med 2012;157:49–58 [22] |
2012 | KDIGOc | No number | Kid Int 2012;2:311–316 [85] |
2012 | National Cancer Center Network (NCCN) | 7–9 g/dl | JNCCN 2012;10:628–53 [5] |
From Goodnough LT. Lancet 2013;391:1845–54 [3].
For patients with acute blood loss.
For patients with symptoms of end-organ ischemia.